Multiagent Adjuvant Therapy Ups Pancreatic Cancer Survival

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Researchers conducted a retrospective cohort study across 48 centers of patients with localized pancreatic adenocarcinoma treated with 2-11 cycles of preoperative FOLFIRINOX.
Medscape Medical News